MedTrace Logo

Prognosis Value of Transient Elastography and Non-invasive Markers of Fibrosis in Patients With Chronic Liver Disease

NCT01241227 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1830

Last updated 2023-07-20

No results posted yet for this study

Summary

The aim of this prospective study was to compare the 5-year prognostic value of transient elastography (TE), FibroTest (FT), APRI , FIB-4, Lok, and Child-Pugh scores for predicting survival and complications of cirrhosis in patients with chronic liver diseases.

Conditions

  • Liver Fibrosis

Sponsors & Collaborators

  • Association HGE CHU Bordeaux Sud

    lead OTHER

Principal Investigators

  • Julien Vergniol, MD · Association HGE CHU Bordeaux Sud

  • Juliette Foucher, MD · Association HGE CHU Bordeaux Sud

  • Eric Terrebonne, MD · Association HGE CHU Bordeaux Sud

  • Wassil Merrouche · Association HGE CHU Bordeaux Sud

  • Victor De Ledinghen, MD, PhD · Association HGE CHU Bordeaux Sud

  • Pierre-Henri Bernard, MD · Association HGE CHU Bordeaux Sud

  • Couzigou Patrice, MD, PhD · Association HGE CHU Bordeaux Sud

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01241227 on ClinicalTrials.gov